Tag: Respicardia

Innovation, Med Tech, Regulatory

Respicardia gets FDA approval for remede system to treat sleep apnea

October 12, 2017


The US Food and Drug Administration (FDA) has approved Respicardia’s transvenous implantable neurostimulation system, remede, for moderate to severe central sleep apnea (CSA) in adults. Remede is designed to activate the phrenic nerve and engage the diaphragm to restore natural […]